Message about the Program

Toward Realization of Integrated Cellular and Gene Therapies

In Japan, more than 10 research projects have started clinical research and trials in the field of regenerative and cellular medicine using iPS cells.

CAR-T therapy attacks cancer cells by modifying immune cells and is already used and attracting attention in the clinic.

The Core Research Center for Next-generation Medicine Utilizing Cell and Gene Therapy (NCGT: Next-generation Cell and Gene Therapy) aims to accelerate the integration of stem cells and genetic technologies to create next-generation medicine.

The four research centers, Center for iPS Cell Research and Application (CiRA), Jichi Medical University, National Center for Child Health and Development, and CiRA Foundation, will function as a central hub to stimulate collaborative research, develop multi-skilled personnel, and promote the integration of stem cell and gene therapy research throughout Japan.

Research RepresentativeJun Takahashi Director/Professor,
CiRA, Kyoto University

Last updated: March 21, 2024